Stereotaxis to Report Second Quarter 2021 Financial Results on August 10, 2021

Rhea-AI Summary

Stereotaxis (STXS) announced the release of its second-quarter financial results for 2021, scheduled for August 10, 2021, before U.S. market opening. The company will hold a conference call at 10 a.m. EST to discuss results and corporate developments. Stereotaxis leads in robotic technologies for cardiac arrhythmias and seeks to improve patient care with advanced, precise systems. This announcement reflects ongoing engagement with investors and provides insight into the company's financial performance.

Positive

• Scheduled release of Q2 2021 financial results indicates transparency and investor communication.
• Leading position in innovative robotic technologies suggests potential for sustained growth.

Negative

• No specific financial metrics or guidance provided for future performance, which may raise investor concerns.

ST. LOUIS, July 20, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will release financial results for its 2021 second quarter on Tuesday, August 10, 2021 before the open of the U.S. financial markets. The Company will host a conference call and webcast at 10 a.m. EST that day to discuss the Company’s results and corporate developments.

What:	Stereotaxis second quarter 2021 financial results conference call
When:	Tuesday, August 10, 2021 at 10:00 a.m. EST (7:00 a.m. PST)
Dial In Number:	To access the live call, dial 800-437-2398 (US and Canada) or 856-344-9206 (International) and give the participant pass code 8321875.
Webcast:	To access the live and replay webcast, please visit the investor relations section of Stereotaxis’ website at http://ir.stereotaxis.com/
Call Replay:	A phone replay of the call will be available for one month beginning approximately two hours following the end of the call. To request access for a replay of the conference call, please Click Here.

About Stereotaxis

Stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The core components of Stereotaxis’ systems have received regulatory clearance in the United States, European Union, Japan, Canada, China, and elsewhere. For more information, please visit www.stereotaxis.com.

Company Contacts:
David L. Fischel
Chairman and Chief Executive Officer

Kimberly Peery
Chief Financial Officer

314-678-6100
investors@stereotaxis.com 

FAQ

When will Stereotaxis release its Q2 2021 financial results?

Stereotaxis will release its Q2 2021 financial results on August 10, 2021, before the market opens.

What time is the Stereotaxis conference call for Q2 2021 results?

The conference call is scheduled for August 10, 2021, at 10 a.m. EST.

How can I access the Stereotaxis Q2 2021 financial results webcast?

The webcast can be accessed in the investor relations section of the Stereotaxis website.

What is Stereotaxis known for in the medical field?

Stereotaxis is the global leader in innovative robotic technologies designed for the treatment of cardiac arrhythmias.